SIRT6 and bladder transitional cell carcinoma: Lastly, we assessed the in vivo functions of SIRT6-UHRF1 axis in BLCA and generated a xnenograft tumor model by subcutaneously injecting UMUC-3 cells, which had been transfected with SIRT6#1 shRNA or control scramble shRNA.